Diagnostic performance of contrast-enhanced CT-scan in sinusoidal obstruction syndrome induced by chemotherapy of colorectal liver metastases: Radio-pathological correlation. Issue 94 (September 2017)

• Record Type: Journal Article
• Authors: Cayet, Sophie; Pasco, Jeremy; Dujardin, Fanny; Besson, Marie; Orain, Isabelle; De Muret, Anne; Miquelestorena-Standley, Elodie; Thiery, Julien; Genet, Thibaud; Le Bayon, Anne-Gwenn
• Is Part Of: European journal of radiology. Issue 94(2017)
• Page Start: 180
• Page End: 190
• Publication Date: 2017-09
• Subjects: 5FU 5-fluorouracil -- CIFH chemotherapy-induced focal hépatopathie -- CLV centrilobular vein -- CRLM colorectal liver metastases -- CT-scan computed tomography scan -- EGFR epidermal growth factor receptor -- HSCT hematopoietic stem cell transplantation -- ICT initial computed tomography scan -- MHL midclavicular hepatic length -- MHV middle hepatic vein -- NC neoadjuvant chemotherapy -- NPV negative predictive value -- NRH nodular regenerative hyperplasia -- OR Odds Ratio -- OX oxaliplatin -- PA pyrrozilidine alkaloids -- PHT portal hypertension -- POCT preoperative computed tomography scan -- PPV predictive positive value -- ROC receiver operating characteristic -- SI sinusoidal injury -- SOS sinusoidal obstruction syndrome -- VEGF vascular endothelial growth factor; Sinusoidal obstruction syndrome -- Liver -- Colorectal neoplasm -- Computed tomography -- Neoadjuvant therapy -- Diagnostic imaging; Medical radiology -- Periodicals; Radiology -- Periodicals; Radiologie médicale -- Périodiques; Medical radiology; Periodicals; 616.075705
• DOI: 10.1016/j.ejrad.2017.06.025
• Languages: English
• ISSNs: 0720-048X

Abstract

Highlights: SOS is a likely side effect of colorectal liver metastases chemotherapy. Clinical diagnosis is not enabled by actual knowledges. This study aimed at establishing preoperative features of SOS on CT-scan. Peripheral hepatic heterogeneity, clover-like sign, increase in spleen size were independent predictors. Abstract: Purpose: Sinusoidal obstruction syndrome (SOS) is a likely side effect of colorectal liver metastases (CRLM) chemotherapy. This study aimed to assess computed tomography scan (CT-scan) performance for SOS diagnosis for patients receiving neoadjuvant chemotherapy (NC) prior to CRLM surgery, comparing obtained results with pathological gold standard. Methods: Preoperative CT-scans of 67 patients who had received a NC prior to liver resection for CRLM from 2011 to 2016 were retrospectively analysed. Positive diagnosis and severity of SOS were established after consensual review of the slides by three pathologists. Preoperative CT-scans were separately interpreted by two radiologists and evocative signs of SOS were sought, defined according to a literature review and operators experience. In order to identify SOS predictors, univariate analysis and multivariate logistic regression were used to study CT-scan signs and pathological results correlation. Results: Twenty-nine patient (43%) had an SOS, 22 (33%) were low-grade and 7 (10%) were high-grade. All patient had received a median of 6 cures (3–27) containing Oxaliplatin for 53 (79%) of them. In univariate analysis, hepatic heterogeneity (p < 0.001), puddle-like or micronodular appearance (p < 0.001), peripheral distribution of heterogeneity (p = 0.085), clover-like sign (p = 0.02), splenomegaly (p = 0.0026), spleen volume increase ≥30% (p = 0.04) or splenic length increase ≥15% (p = 0.04), as well as the subjective impression of the observer (P < 0.001) were significantly associated with SOS diagnosis. In multivariate analysis, clover-like sign (OR 1.87, 95% CI 1.18–2.95, p = 0.0081), increase in spleen volume ≥30% (OR 1.29, 95% CI 1.01–1.64, p = 0.04), and the peripheral distribution of heterogeneity (OR 1.53, 95% CI 1.21–1.94, p < 0.001) were independent SOS predictors. The area under the ROC curve was 0.804. The inter-observer agreement for SOS diagnosis was moderate (Kappa = 0.546). Conclusion: CT-scan can detect suggestive signs of SOS in patients receiving chemotherapy for CRLM. By integrating clinical and biological information into CT-scan data, it may be fruitful to create a positive diagnostic and severity score for chemotherapy-induced SOS.